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Abstract 
N-β-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine (5-S-GAD), an antibacterial substance 
isolated from the flesh fly, has been described as having multipotential biological activities toward 
various tissues. In a previous paper, we reported a novel neuroprotective action of 5-S-GAD on rat 
retinal ganglion cell apoptosis induced by optic nerve injury and intraocular N-methyl-D-aspartate 
treatment in vivo. In the present study, we further investigated the protective mechanism of this small 
peptide against other types of apoptosis in cultured cells of the established rat retinal ganglion cell 
line RGC-5. Hydrogen peroxide and serum deprivation treatments induced intracellular reactive 
oxygen species levels and lipid peroxidation, revealed by 4-hydroxy-2-nonenal production, in 
RGC-5 cells within 9-12 h. The treatments also induced cell death accompanied by nuclear 
condensation, DNA laddering and increases in apoptotic Bax and caspase-3 proteins in RGC-5 cells 
within 12-24 h. 5-S-GAD at 25-50 μM clearly suppressed the cell death and apoptotic features 
induced by these treatments. 5-S-GAD restored the nuclear condensation, DNA laddering and 
increases in apoptotic proteins. Furthermore, 5-S-GAD directly activated anti-apoptotic phospho-Akt 
and Bcl-2 proteins in RGC-5 cells. 5-S-GAD also quenched the reactive oxygen species production 
and inhibited the lipid peroxidation induced by oxidative stress. Therefore, 5-S-GAD may 
complementarily protect RGC-5 cells against apoptosis through dual actions as a radical scavenger 
and an inducer of anti-apoptotic phospho-Akt and Bcl-2. Taken together, 5-S-GAD is a 
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1. Introduction 
Retinal ganglion cells (RGCs) play key roles in integrating visual information and relaying it to 
the visual center of the brain through the optic nerve. Apoptosis of RGCs is known to be a 
fundamental pathogenesis in a variety of retinal degenerative diseases, such as glaucoma and 
diabetic retinopathy (Quigley et al. 1995; Barber et al. 1998; Lafuente et al. 2001). Several common 
mechanisms, such as excitotoxicity, oxidative stress ischemia and deficiency of trophic factors, have 
been proposed to be involved in RGC apoptosis (Wadia et al. 1998; Pease et al. 2000; Maher and 
Hanneken 2005). To further elucidate the molecular mechanism of RGC apoptosis, a transformed rat 
RGC cell line, RGC-5, was recently established (Krishnamoorthy et al. 2001). The signaling 
pathways leading to RGC apoptosis have been studied under glaucomatous and diabetic conditions 
using this cell line (Tatsumi et al. 2008; Nakajima et al. 2008). In a previous study, we showed that a 
novel small peptide, N-β-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine (5-S-GAD), protects 
against cell death of rat RGCs after treatment with N-methyl-D-aspartate (NMDA) or optic nerve 
injury in in vivo models (Koriyama et al. 2008). 5-S-GAD was originally isolated from the adult 
flesh fly as a defense substance produced in response to bacterial injection or body injury (Leem et 
al. 1996). 5-S-GAD inhibits the cell growth of some human tumor cells in vitro (Akiyama et al. 
2000) and angiogenesis of mouse 8180 sarcoma cells in vivo (Nishikawa et al. 2006). The exact 
mechanism of the actions of 5-S-GAD on various types of cells and tissues has remained unclear. In 
the present study, we aimed to clarify the neuroprotective actions of 5-S-GAD on rat RGC apoptosis 
by investigating its effects on the cell death of RGC-5 cells in oxidative stress and trophic support 
interruption models. 5-S-GAD (25 or 50 μM) significantly prevented RGC-5 cells from undergoing 
cell death induced by hydrogen peroxide exposure and serum deprivation. 5-S-GAD clearly 
quenched the production of peroxide radicals and inhibited lipid peroxidation. Furthermore, 
5-S-GAD directly activated anti-apoptotic phospho-Akt and Bcl-2 proteins in RGC-5 cells. 
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Therefore, 5-S-GAD may complementarily protect RGC-5 cells against apoptosis through dual 
actions as a radical scavenger and an activator of anti-apoptotic phospho-Akt and Bcl-2. The present 




  ---Fig. 1 
2.1. 5-S-GAD protects against RGC-5 cell death induced by oxidative stress 
The cell death of cultured RGC-5 cells was evaluated using an MTT reduction assay. First, we 
investigated the effects of 5-S-GAD on the cell viability of RGC-5 cells cultured for 24 h. 5-S-GAD 
alone did not affect the cell viability at concentrations of 5-50 μM (Fig. 1A). Therefore, we used 
5-S-GAD at concentrations of 5-50 μM in our subsequent experiments. Next, we investigated the 
effects of 5-S-GAD on the neurotoxicity induced by hydrogen peroxide exposure and serum 
deprivation conditions in RGC-5 cells. Exposure to hydrogen peroxide (300-600 μM) clearly 
induced cell death in one-half of the cells within 24 h (Fig. 1A). 5-S-GAD suppressed the cell death 
induced by 300 μM hydrogen peroxide in a dose-dependent manner. 5-S-GAD at 50 μM completely 
suppressed the cell death induced by hydrogen peroxide to the level of the control cells (Fig. 1A). 
Serum deprivation rapidly induced cell death in more than one-half of the RGC-5 cells within 24 h 
(Fig. 1B). 5-S-GAD also protected against the cell death induced by serum deprivation in a 
dose-dependent manner. 5-S-GAD at 50 μM completely inhibited the cell death induced by serum 
deprivation to the level of the control cells (Fig. 1B). 
                      ---Fig. 2   
2.2. 5-S-GAD protects against RGC-5 cell apoptosis induced by oxidative stress 
RGC-5 cells treated with 300 μM hydrogen peroxide for 24 h were stained with Hoechst 33258. 
RGC-5 cells treated with hydrogen peroxide showed nuclear chromatin condensation following 
staining with Hoechst 33258 (Fig. 2B) relative to the control cells (Fig. 2A). 5-S-GAD (50 μM) 
clearly suppressed the nuclear condensation induced by hydrogen peroxide (Fig. 2C). Quantification 
of the staining confirmed protective effects of 25-50 μM 5-S-GAD on the nuclear condensation 
induced by 300 μM hydrogen peroxide in RGC-5 cells (Fig. 2D), whereas 5-S-GAD alone had no 
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effect on the nuclear condensation. Furthermore, nuclear DNA extracted from RGC-5 cells treated 
with hydrogen peroxide for 24 h was subjected to electrophoresis (Fig. 2E), and exhibited a DNA 
fragmentation pattern (Fig. 2E, lane H) compared with nuclear DNA extracted from control cells 
(Fig. 2E, lane C). 5-S-GAD significantly inhibited the DNA fragmentation (Fig. 2E, lane HG). 
5-S-GAD alone had no effect on the DNA fragmentation in RGC-5 cells (Fig. 2E, lane G). 
         ---Fig. 3 
2.3. 5-S-GAD decreases the fluorescence intensity in hydrogen peroxide treated RGC-5 cells 
RGC-5 cells were incubated with the fluorescent dye CM-H2DCFDA, a trapping marker for ROS 
production. After 9 h in culture, 300 μM hydrogen peroxide increased fluorescence intensity 
including hydrogen peroxide itsekf (Nakajima et al., 2009) by 1.75-fold relative to the control cells 
(compare Fig. 3D-F with Fig. 3A-C; Fig. 3J). 5-S-GAD (50 μM) completely blocked the increase in 
fluorescence intensity induced by hydrogen peroxide (Fig. 3G-I). 5-S-GAD alone had no effect on 
the ROS levels in RGC-5 cells (Fig. 3J).  
         ---Fig. 4 
2.4. 5-S-GAD protects against ROS production and DNA fragmentation induced by serum 
deprivation in RGC-5 cells 
Similarly, we used CM-H2DCFDA staining to investigate the effects of 5-S-GAD on the ROS 
production induced by serum deprivation. After 9 h in culture under serum deprivation conditions, 
many fluorescent cells were observed compared with control cells (compare Fig. 4D-F with Fig. 
4A-C). 5-S-GAD clearly blocked the fluorescence intensity induced by serum deprivation (Fig. 
4G-1). 5-S-GAD at 50 μM completely blocked the ROS production induced by serum deprivation 
(Fig. 4J). Furthermore, 5-S-GAD completely blocked the DNA fragmentation (Fig. 4K, compare 
lane SG with lane S) to a similar level to the control cells (Fig. 4K, lane C). 
         ---Fig. 5 
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2.5. 5-S-GAD protects against lipid peroxidation induced by oxidative stress in RGC-5 cells 
4-HNE is a final product of lipid peroxidation (Lim et al. 2006). Therefore, we investigated the 
effects of 5-S-GAD on lipid peroxidation by dot blot analyses using an anti-4-HNE antibody. After 
12 h in culture, hydrogen peroxide at 300 μM significantly increased the level of 4-HNE production 
by 1.7-fold relative to the control cells (Fig. 5A). 5-S-GAD dose-dependently suppressed the 
increase in 4-HNE induced by hydrogen peroxide. 5-S-GAD at 50 µM completely blocked the lipid 
peroxidation (Fig. 5A), whereas 5-S-GAD alone had no effect on the production of 4-HNE. Similarly, 
5-S-GAD suppressed the increase in lipid peroxidation induced by serum-free conditions (Fig. 5B). 
The intensities of the β-actin spots remained unchanged by these treatments.  
         ---Fig. 6 
2.6. 5-S-GAD directly activates anti-apoptotic phospho-Akt and Bcl-2 in RGC-5 cells 
Since 5-S-GAD actually prevented the apoptotic features induced by hydrogen peroxide and serum 
deprivation as described above, we investigated the effects of 5-S-GAD on cell death and cell 
survival signal expressions under hydrogen peroxide exposure. Hydrogen peroxide clearly increased 
the levels of Bax by 1.5-fold and caspase-3 by 1.8-fold within 12 h (Fig. 6A, upper bands and 6B, 
respectively). 5-S-GAD reversed the hydrogen peroxide-induced increases in the levels of Bax and 
caspase-3 expression to the levels in control cells. In contrast, hydrogen peroxide decreased the 
levels of anti-apoptotic proteins to 30% of the control for phospho-Akt and 75% of the control for 
Bcl-2 within 12 h (Fig. 6C, upper bands and 6D, respectively). 5-S-GAD reversed the hydrogen 
peroxide-induced decreases in the levels of phospho-Akt and Bcl-2 to the levels in control cells. 
Furthermore, 5-S-GAD directly activated phospho-Akt by 1.5-fold and Bcl-2 by 1.2-fold in RGC-5 
cells within 12 h (Fig. 6C, upper bands and 6D, respectively). The levels of β-actin bands were not 
changed during this treatment (Fig. 6A, lower bands). Levels of non-active form of Akt protein did 
not change during this treatment (Fig. 6C, lower). These data indicate that 5-S-GAD activates 
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3.1. 5-S-GAD protects RGC-5 cells against apoptosis induced by oxidative stress 
Based on our previous data for rat RGCs after optic nerve injury or NMDA treatment in vivo 
(Koriyama et al. 2008), the question arose as to whether 5-S-GAD protects RGCs against the 
apoptosis induced by other types of insults. The eye has a 3-4-fold higher oxygen consumption than 
brain tissue and consequently has a high risk of exposure to various types of oxygen radicals, such as 
hydroxy radicals, hydrogen peroxide and superoxide anions. This is the reason why the eye is a 
unique tissue that contains very high quantities of anti-oxidants, such as superoxide dismutase, 
catalase, ascorbate and vitamin E (Rao et al. 1985; Rao 1990; Atalla et al. 1987). In the present study, 
we chose to examine oxidative stress and trophic support interruption treatments to evaluate the 
neuroprotective action of 5-S-GAD on RGC apoptosis. We used the established rat RGC cell line 
RGC-5 as a model cell type for RGCs (Krishnamoorthy et al. 2001). As a model of oxidative stress, 
we treated RGC-5 cells with hydrogen peroxide. Hydrogen peroxide at a concentration of 300 μM is 
sufficient to induce cell damage, including apoptosis (Nakajima et al. 2008). As a model of trophic 
support interruption, we cultured RGC-5 cells under serum deprivation. Both treatments are well 
characterized to induce RGC-5 cell apoptosis (Charles et al. 2005; Tatsumi et al. 2008). 5-S-GAD at 
25-50 μM almost completely blocked the hydrogen peroxide-induced RGC-5 cell apoptosis, as 
evaluated by the MTT cell viability assay, nuclear condensation, DNA laddering and increases in 
Bax and caspase-3 within 24 h. 5-S-GAD also blocked the ROS levels and inhibited lipid 
peroxidation in RGC-5 cells, as evaluated by increases in CM-H2DCFDA fluorescence and 4-HNE 
production within 12 h. In the case of hydrogen peroxide treated cells, CM-H2DCFDA detected not 
only ROS production but also hydrogen peroxide itself. However, GAD significantly suppressed the 
levels of fluorescence intensity by hydrogen peroxide treatment. 
Charles et al. (2005) studied the signal cascade for RGC-5 cell apoptosis under serum deprivation 
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conditions. They demonstrated that serum deprivation induces an increase in malonylaldehyde, a 
decrease in reduced glutathione and dysfunction of mitochondria leading to caspase-3 activation. 
5-S-GAD at 25-50 μM similarly blocked the serum deprivation-induced RGC-5 cell apoptosis. 
5-S-GAD inhibited the apoptotic features, as well as ROS production and lipid peroxidation. Our 
data strongly suggest that 5-S-GAD has a wide protective spectrum against the RGC apoptosis 
induced by oxidative stress and trophic deficiency in the present study and by optic nerve injury and 
NMDA treatment in our previous study (Koriyama et al. 2008). However, the concentrations of 
5-S-GAD used in the previous in vivo study (0.2-2 pmol) and the present in vitro study (25-50 μM) 
are different. It may be due to the big differences in the experimental conditions, particularly the 
duration of the 5-S-GAD exposure. 
 
3.2. Possible mechanism for the neuroprotective actions of 5-S-GAD toward RGC apoptosis 
In a previous paper (Koriyama et al. 2008), we reported that intraocular 5-S-GAD activates 
phospho-Akt by 2.0-fold and Bcl-2 by 1.8-fold in rat RGCs at 1-3 days and 3-5 days after treatment, 
respectively. The second question that arose from that study was whether the activation of 
anti-apoptotic proteins by 5-S-GAD is direct or indirect in RGCs. The present data clearly showed 
that these effects were direct. 5-S-GAD induced low, but significant, activation of phospho-Akt by 
1.5-fold and Bcl-2 by 1.2-fold in RGC-5 cells within 12 h. The magnitudes of the phospho-Akt and 
Bcl-2 activation levels differed between the in vivo and in vitro situations. This may also be due to 
the big differences in the experimental conditions. 5-S-GAD almost recovered the phospho-Akt and 
Bcl-2 levels from the decreased levels after hydrogen peroxide treatment. 5-S-GAD also recovered 
the phospho-Akt and Bcl-2 levels from the decreased levels induced by serum deprivation (data not 
shown). These results suggest that the restoration of the phospho-Akt level in RGC-5 cells is caused 
by the activation of anti-apoptotic proteins by 5-S-GAD. However, the restoration of ROS 
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production and lipid peroxidation by 5-S-GAD did not seem to be caused by this activation of 
anti-apoptotic proteins. 
Recently, Akiyama et al. (2009) reported a novel radical scavenging action of 5-S-GAD. They 
clearly demonstrated that 5-S-GAD scavenges 1.1-diphenylpicrylhydrazyl and superoxide anion 
radical, and inhibits lipid peroxidation. The effective dose of 5-S-GAD for scavenging the free 
radicals and inhibiting the lipid peroxidation is ~50 μM, which is in the same order in magnitude as 
that in the present study. They also showed that 5-S-GAD inhibits the onset of 
glucocorticoid-induced lens opacification in the chick (Akiyama et al. 2009). If the radical 
scavenging action of 5-S-GAD is applicable to the present study, the protective actions of 5-S-GAD 
toward RGC-5 cell apoptosis can be fully explained by complementation of the activation of 
anti-apoptotic proteins. Therefore, the neuroprotective mechanism of 5-S-GAD is composed of dual 
actions, one as an inducer of the anti-apoptotic proteins phospho-Akt and Bcl-2 and the other as a 
radical scavenger. Although we do not know the exact radical species generated under serum 
deprivation and hydrogen peroxide treatments, 5-S-GAD effectively quenched ROS production and 
inhibited lipid peroxidation. The pathogenesis of RGC apoptosis induced by optic nerve injury and 
NMDA treatment in vivo is also well known to involve ROS generation (Castagné et al. 1996; 
El-Remessy et al. 2003; Inomata et al. 2006). Taken together, the findings in the previous in vivo and 
present in vitro studies strongly indicate that 5-S-GAD is one of the high-potential tools for rescuing 









4. Experimental procedures 
4.1. Cell culture 
RGC-5 cells were kindly gifted by Dr. N. Agarwal, University of North Texas Health Science 
Center and Dr. H. Hara, Gifu Pharmaceutical University. RGC-5 cells were cultured in low-glucose 
Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal calf serum (FBS), 100 U/ml 
penicillin and 100 μg/ml streptomycin in a humidified atmosphere of 95% air and 5% CO2 at 37°C. 
The cells were passaged by trypsinization every 3-4 days. 
 
4.2. Cell treatments 
RGC-5 cells (5×10
3
 cells/ml) were cultured overnight as described above. After washing with 
DMEM, the cells were divided into three groups: (1) control group: (2) hydrogen peroxide-treated 
group; and (3) serum deprivation group. Control and the hydrogen peroxide-treated group were 
cultured in medium containing 1% FBS to reduce cell growth as much as possible (Nakajima et al. 
2008), whereas the serum deprivation groups were cultured in serum-free medium. 5-S-GAD was a 
generous gift from Dr. S. Natori, RIKEN. The protective effects of 5-S-GAD were analyzed after 
simple addition of hydrogen peroxide or serum deprivation treatment. The cells were pretreated with 
5-S-GAD for 1 h before hydrogen peroxide or serum deprivation loading.  
 
4.3. MTT assay 
The cell death was estimated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) reduction assay. An aliquot (20 μl) of 2.75 mg/ml MTT in phosphate-buffered saline 
(PBS) was added to 200 μl of each culture medium as described previously (Koriyama et al. 2003). 
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The reaction mixtures were incubated at 37°C for 3 h, prior to the addition of 200 μl 
HCl/isopropanol. The produced formazan was measured by its absorbance at 550 nm using a plate 
reader (Model 680, Bio-Rad Laboratories, Hercules, CA). The experiments were repeated at least 
three times and compared with control experiments. 
 
4.4. Nuclear staining with Hoechst 33258 
Cultured RGC-5 cells were washed twice with PBS and fixed with 0.1% glutaraldehyde in PBS at 
room temperature for 15 min. After the fixation, the cells were washed and incubated with Hoechst 
33258 (Wako; 100 μg/ml in PBS) at room temperature for 15 min. The cells with chromatin 
condensation were observed and counted in 25 visual fields/dish by fluorescence microscopy. 
 
4.5. DNA fragmentation 
Cultured RGC-5 cells were collected, suspended in PBS and centrifuged at 400 × g for 10 min. 
The cell pellet was resuspended and lysed in a lysis buffer (Tris-HCl pH 8.0, 10 mM NaCl, 10 mM 
EDTA, 1% SDS). The lysed samples were treated with RNase (0.4 μg/ml) and proteinase K (0.625 
mg/ml) for 1 h at 37°C. Agarose gel (2%) electrophoresis of the isolated DNA was performed in 40 
mM Tris-HCl buffer (pH 8.0) containing 2 mM EDTA, and the DNA bands were visualized after 
staining with ethidium bromide (0.5 μg/ml) for 15 min at room temperature. 
 
4.6. Measurement of reactive oxygen species (ROS) 
The fluorescent probe 5,6-chloromethyl-2,7-dichlorodihydrofluorescein diacetate acetyl ester 
(CM-H2DCFDA; Molecular Probes) is a cell-permeable indicator of ROS (Shimazawa et al. 2005). 
RGC-5 cells were cultured for 9 h, washed twice with Hanks balanced salt solution (HBSS) and 
treated with CM-H2DCFDA (10 μM) for 1 h at 37°C. The samples were then centrifuged at 100 × g 
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for 5 min at room temperature. The supernatants were discarded and 800 μl of HBSS was added to 
each cell pellet. The fluorescence intensity of each cell suspension was measured by the emission at 
520 nm after excitation at 485 nm using a Fluoroskan Ascent plate reader (Thermo Labsystem) . The 
total cell number was evaluated by Hoechst 33258 nuclear staining. 
4.7. Western blotting analysis 
RGC-5 cells cultured under various conditions for 12 h were extracted and aliquots (15 μg of 
protein) were subjected to SDS-PAGE using a 12.5% gel as described previously (Koriyama et al. 
2003). The separated proteins were transferred to a nitrocellulose membrane and incubated with 
primary and secondary antibodies as described previously (Koriyama et al. 2007). The signals for the 
antibody-bound protein bands (28 kDa for Bax; 26 kDa for Bcl-2; 17 kDa for active caspase-3; 56 
kDa for phospho-Akt) were detected using 3-diaminobendizine tetrahydrochloride (DAB) as a 
substrate. An antibody against β-actin was used as an internal standard. The protein bands produced 
by samples from cells under various culture conditions were analyzed densitometrically using the 
Scion Image Software (Scion Corp.). All experiments were repeated at least three times. 
 
4.8. Dot blotting analysis for 4-hydroxy-2-nonenal (4-HNE) 
After the western blot analysis, equal amounts of protein (15 μg) were applied to a Hybri-SLOT 
apparatus (Gibco BRL) and transferred to a nitrocellulose membrane (Whatman) by vacuum 
filtration. After blocking with 3% BSA for 1 h at room temperature, the samples were incubated with 
an anti-4-HNE antibody (1:100; NOF Corporation) for 12 h at 4°C, followed by incubation with a 
peroxidase-conjugated anti-mouse IgG antibody (1:500, Santa Cruz Biotechnology, CA, USA) for 1 
h at room temperature. Antibody-bound protein bands were detected using DAB as a substrate and 
analyzed densitometrically as described above. All experiments were repeated at least three times. 
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4.9. Statistical analysis 
The values for the cell death, number of positively stained cells with fluorescence probe and 
densitometrically analyzed protein bands were calculated as the means ± SEM from 3-5 independent 
experiments. Statistical significance was determined as values of P<0.05 using one-way ANOVA 
followed by multiple comparisons by Dunnett’s test. 
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Fig. 1. Protective effects of 5-S-GAD on RGC-5 cell death induced by hydrogen peroxide and serum 
deprivation treatments. Cell viability was estimated by the MTT assay. (A) RGC-5 cells were 
cultured with 5-S-GAD at 5-50 μM for 24 h. Hydrogen peroxide at 300-600 μM induces cell death 
of RGC-5 cells to 55% of the control level within 24 h. 5-S-GAD at 25-50 μM completely blocks the 
cell death induced by hydrogen peroxide. *P<0.01 vs. control cells; 
+
P<0.01 vs. hydrogen peroxide 
treatment (n=6). (B) Serum deprivation induces cell death to 35% of the control level. 5-S-GAD 
completely blocks the cell death induced by serum deprivation. *P<0.01 vs. control cells; 
+
P<0.01 vs. 
serum deprivation (n=6). 
 
Fig. 2. Prevention of hydrogen peroxide-induced RGC-5 cell apoptosis by 5-S-GAD. (A-C) Nuclear 
condensation of RGC-5 cells revealed by Hoechst 33258 staining. (A) Control cells. (B) Cells 
treated with hydrogen peroxide (300 μM). (C) Cells treated with hydrogen peroxide (300 μM) plus 
5-S-GAD (50 μM). Note the suppression of nuclear condensation by 5-S-GAD (C) compared with 
the hydrogen peroxide treatment (B). (D) Quantitative data for the cell numbers with positive 
staining. *P<0.01 vs. control cells; 
+
P<0.01 vs. hydrogen peroxide treatment (n=5). (E) DNA 
fragmentation in a 2% agarose gel. 5-S-GAD prevents the DNA laddering induced by hydrogen 
peroxide. Lane M: 100-bp markers; lane C: control cells; lane G: cells treated with 5-S-GAD; lane 
H: cells treated with hydrogen peroxide; lane HG: cells treated with hydrogen peroxide plus 
5-S-GAD. 
 
Fig. 3. Decrease of hydrogen peroxide-induced fluorescence intensity by 5-S-GAD. ROS levels in 
RGC-5 cells was evaluated by CM-H2DCFDA staining (A, D, G). RGC-5 cell apoptosis was 
evaluated by staining with Hoechst 33258 (B, E, H). Merged images of CM-H2DCFDA and Hoechst 
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33258 staining (C, F, I). (A-C) Control cells. (D-F) Cells treated with hydrogen peroxide. (G-I) Cells 
treated with hydrogen peroxide plus 5-S-GAD (50 μM). (J) Quantitative data for fluorescence 
intensity measured using a fluorescence plate reader. *P<0.01 vs. control cells; 
+
P<0.01 vs. hydrogen 
peroxide treatment (n=5). 
 
Fig. 4. Prevention of serum deprivation-induced ROS production and DNA fragmentation by 
5-S-GAD. RGC-5 cells were cultured under serum-free conditions with or without 5-S-GAD for 9 h. 
(A, D, G) CM-H2DCFDA staining. (B, E, H) Hoechst 33258 staining. (C, F, I) Merged images of 
CM-H2DCFDA and Hoechst 33258 staining. (A-C) Control cells. (D-F) Cells treated with serum 
deprivation. (G-I) Cells treated with serum deprivation plus 5-S-GAD (50 μM). (J) Quantitative data 
for ROS production measured using a fluorescence plate reader. *P<0.01 vs. control cells; 
+
P<0.01 
vs. serum deprivation treatment (n=5). (K) DNA fragmentation in an agarose gel. Lane M: 100-bp 
DNA markers; lane C: control cells; lane G: cells treated with 5-S-GAD; lane S: cells treated with 
serum deprivation; lane SG: cells treated with serum deprivation plus 5-S-GAD. 
 
Fig. 5. Prevention of hydrogen peroxide- and serum deprivation-induced 4-HNE production by 
5-S-GAD. RGC-5 cells were cultured under hydrogen peroxide exposure or serum-free conditions 
with or without 5-S-GAD for 12 h. 4-HNE production was measured by dot blotting analyses with 
an anti-4-HNE antibody. 5-S-GAD blocks the increases in 4-HNE induced by hydrogen peroxide (A) 
and serum deprivation (B). Levels of β-actin bands were not changed during these treatments. 
*P<0.01 vs. control cells; 
+
P<0.01 vs. hydrogen peroxide or serum deprivation treatment (n=5).  
 
Fig. 6. Activation of anti-apoptotic proteins in RGC-5 cells induced by 5-S-GAD. Apoptotic or 
anti-apoptotic proteins in RGC-5 cells treated with hydrogen peroxide or hydrogen peroxide plus 
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5-S-GAD were analyzed by western blotting. (A) Bax. 5-S-GAD restores the increase in Bax 
induced by hydrogen peroxide treatment (upper bands). *P<0.01 vs. control cells; +P<0.01 vs. 
hydrogen peroxide treatment (n=3). β-Actin remains unchanged by the treatments (lower bands). (B) 
Caspase-3. 5-S-GAD restores the increase in caspase-3 induced by hydrogen peroxide treatment. 
*P<0.01 vs. control cells; 
+
P<0.01 vs. hydrogen peroxide treatment (n=3). (C) Akt. 5-S-GAD 
restores the decrease in phospho-Akt induced by hydrogen peroxide to the control level (upper 
bands). Note the induction of phospho-Akt by 5-S-GAD alone. *P<0.01 vs. control cells; 
+
P<0.01 vs. 
hydrogen peroxide treatment (n=3). Akt remains unchanged by any of the treatments (lower bands). 
(D) Bcl-2. 5-S-GAD restores the decrease in Bcl-2 induced by hydrogen peroxide treatment. Note 
the induction of Bcl-2 by 5-S-GAD alone. *P<0.01 vs. control cells; 
+
P<0.01 vs. hydrogen peroxide 
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